Skip to main content

Find Clinical Trials

Home
Conditions
Lupus Nephritis

Clinical trial condition

Lupus Nephritis

Explore clinical trials studying Lupus Nephritis. Study availability and eligibility vary by location and protocol.

162 public trials 48 recruiting studies

Refine in advanced search Browse all conditions

Lupus Nephritis trial results

Completed

Prospective Study of TW in the Treatment of LN Type V With Gross Proteinuria

NCT00935389

Conditions: Autoimmune Diseases, CTX, Connective Tissue Diseases, +17 more
Locations: Research Institute of Nephrology, Jinling Hospital Nanjing, Jiangsu, China

Research Institute of Nephrology,Jinling Hospital Nanjing, Jiangsu, China

View Trial Details

Completed

Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare

NCT00423098

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations: Novartis Bogotá, Colombia

Novartis Créteil, France

Novartis Nantes, France

Novartis Investigative Site Paris, France

View all 17 locations

View Trial Details

Completed

To Compare the Efficacy and Safety of Tripterygium (TW) Versus AZA in the Maintenance Therapy for Lupus Nephritis

NCT00881309

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations: Research Institute of Nephrology,Jinling Hospital Nanjing, Jiangsu, China

View Trial Details

Completed

Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study

NCT00976300

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
Locations: Department of Rheumatology, Faculty of Medicine, Charles University in Prague Hradec Králové, Czechia

Department of Rheumatology, Faculty of Medicine, Palacky University Olomouc, Czechia

Department of Nephrology, General Teaching Hospital and First faculty of Medicine, Charles University in Prague Prague, Czechia

Institute of Rheumatology Prague, Czechia

View Trial Details

Completed

To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN

NCT00302549

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations: Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine Nanjing, Jiangsu, China

View Trial Details

Completed

Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus Nephritis

NCT00615173

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +14 more
Locations: The 1st Affiliated Hospital, Sun Yet-sen University Guangzhou, Guangdong, China

View Trial Details

Completed

BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis

NCT00001789

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +15 more
Locations: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Bethesda, Maryland, United States

View Trial Details

Completed

Cyclophosphamide and Fludarabine to Treat Lupus Nephritis

NCT00001676

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +13 more
Locations: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Bethesda, Maryland, United States

View Trial Details

Completed

Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative Study

NCT00429377

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations: Chubu Region, Japan

Hokkaido Region, Japan

Hokuriku Region, Japan

Kansai Region, Japan

View Trial Details

Completed

Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease

NCT00035308

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +14 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Rheumatology Associates of North Alabama Huntsville, Alabama, United States

Montgomery Rheumatology Associates Montgomery, Alabama, United States

Arizona Arthritis & Rheumatology Paradise Valley, Arizona, United States

View all 82 locations

View Trial Details